Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multi Indocitra Tbk. (MICE) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multi Indocitra Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multi Indocitra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Multi Indocitra Tbk. trades at Rp520 (market cap 312B, 100 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2× Multi Indocitra Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 100). Which is the better fit depends on your goals.

LABSMICE
Market Cap
635.95B312B
Volume
843K100
Lot
8.43K1
Turnover
137.6M52K
Average Price
163.22520
Value
137.6M52K
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MICE
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multi Indocitra Tbk.

PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.

Read more on MICE